Person Overview

General Partner at Wellington Partners



Regina Hodits joined Wellington Partners in spring 2010 as a part-time advisor and stepped up to General Partner in January 2011. Since 2000, she has become an influential investor in the European venture capital industry, focusing on early-stage and growth deals in Life Sciences. Her industry experience and her strong scientific background will help the Wellington Life Sciences team to strengthen its position in the European investment market.

Until January 2010, Regina led the life sciences efforts of Atlas Venture in Europe, a leading transatlantic venture capital firm. As a Partner at Atlas Venture, she led numerous financing rounds and was the founding investor in Bicycle Therapeutics, Fibrex, F-star and Jenavalve. In addition, she served on the Board of Egalet, Lumavita, Novamed and Protaffin and is an external director at GlaxoSmithKline's (GSK) Respiratory CEDD. Regina was also on the Board of U3 Pharma, which... See More

Experience (1)